These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 33309522)
1. Medicaid prescription limits and their implications for naloxone accessibility. Roberts AW; Look KA; Trull G; Carpenter DM Drug Alcohol Depend; 2021 Jan; 218():108355. PubMed ID: 33309522 [TBL] [Abstract][Full Text] [Related]
2. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid. Gertner AK; Domino ME; Davis CS Drug Alcohol Depend; 2018 Sep; 190():37-41. PubMed ID: 29966851 [TBL] [Abstract][Full Text] [Related]
3. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018. Lee B; Zhao W; Yang KC; Ahn YY; Perry BL JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816 [TBL] [Abstract][Full Text] [Related]
4. Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates. Gangal NS; Hincapie AL; Jandarov R; Frede SM; Boone JM; MacKinnon NJ; Koechlin K; DeFiore-Hyrmer J; Holthusen A; Heaton PC JAMA Netw Open; 2020 Jan; 3(1):e1920310. PubMed ID: 32003819 [TBL] [Abstract][Full Text] [Related]
5. The Opioid Crisis and the Physician's Role in Contributing to its Resolution: Step One--Prevention of Overdoses. Wolfe S; Bouffard DL; Modesto-Lowe V Conn Med; 2016; 80(6):325-34. PubMed ID: 27509638 [TBL] [Abstract][Full Text] [Related]
6. Legal requirements and recommendations to prescribe naloxone. Haffajee RL; Cherney S; Smart R Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248 [TBL] [Abstract][Full Text] [Related]
7. Community-based opioid overdose prevention programs providing naloxone - United States, 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174 [TBL] [Abstract][Full Text] [Related]
8. Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States. Sohn M; Talbert JC; Huang Z; Lofwall MR; Freeman PR JAMA Netw Open; 2019 Jun; 2(6):e196215. PubMed ID: 31225895 [TBL] [Abstract][Full Text] [Related]
9. The changing landscape of naloxone availability in the United States, 2011 - 2017. Freeman PR; Hankosky ER; Lofwall MR; Talbert JC Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192 [TBL] [Abstract][Full Text] [Related]
12. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372 [TBL] [Abstract][Full Text] [Related]
13. Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant). You HS; Ha J; Kang CY; Kim L; Kim J; Shen JJ; Park SM; Chun SY; Hwang J; Yamashita T; Lee SW; Dounis G; Lee YJ; Han DH; Byun D; Yoo JW; Kang HT Medicine (Baltimore); 2020 May; 99(22):e20033. PubMed ID: 32481373 [TBL] [Abstract][Full Text] [Related]
14. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location. Kohan LR; Elmofty D; Pena I; Liao C J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425 [TBL] [Abstract][Full Text] [Related]
15. Opioid education and nasal naloxone rescue kits in the emergency department. Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910 [TBL] [Abstract][Full Text] [Related]
16. Opioid-overdose laws association with opioid use and overdose mortality. McClellan C; Lambdin BH; Ali MM; Mutter R; Davis CS; Wheeler E; Pemberton M; Kral AH Addict Behav; 2018 Nov; 86():90-95. PubMed ID: 29610001 [TBL] [Abstract][Full Text] [Related]
17. Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey. Cone DC; Bogucki S; Burns K; D'Onofrio G; Hawk K; Joseph D; Fiellin DA J Addict Med; 2020 Dec; 14(6):e369-e371. PubMed ID: 33031212 [TBL] [Abstract][Full Text] [Related]
18. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732 [TBL] [Abstract][Full Text] [Related]
19. Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose. Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM JAMA Intern Med; 2024 Aug; 184(8):954-962. PubMed ID: 38884975 [TBL] [Abstract][Full Text] [Related]
20. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]